Identification of Blood Transport Proteins to Carry Temoporfin: A Domino Approach from Virtual Screening to Synthesis and In Vitro PDT Testing
Temoporfin (mTHPC) is one of the most promising photosensitizers used in photodynamic therapy (PDT). Despite its clinical use, the lipophilic character of mTHPC still hampers the full exploitation of its potential. Low solubility in water, high tendency to aggregate, and low biocompatibility are the...
Main Authors: | Alessia Marconi, Giulia Giugliano, Matteo Di Giosia, Tainah Dorina Marforio, Michele Trivini, Eleonora Turrini, Carmela Fimognari, Francesco Zerbetto, Edoardo Jun Mattioli, Matteo Calvaresi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/3/919 |
Similar Items
-
Carrying Temoporfin with Human Serum Albumin: A New Perspective for Photodynamic Application in Head and Neck Cancer
by: Edoardo Jun Mattioli, et al.
Published: (2022-12-01) -
Evaluation for Synergistic Effects by Combinations of Photodynamic Therapy (PDT) with Temoporfin (mTHPC) and Pt(II) Complexes Carboplatin, Cisplatin or Oxaliplatin in a Set of Five Human Cancer Cell Lines
by: Carsten Lange, et al.
Published: (2018-10-01) -
Comparison of Cellular Death Pathways after mTHPC-mediated Photodynamic Therapy (PDT) in Five Human Cancer Cell Lines
by: Carsten Lange, et al.
Published: (2019-05-01) -
mTHPC-Loaded Extracellular Vesicles Significantly Improve mTHPC Diffusion and Photodynamic Activity in Preclinical Models
by: Marie Millard, et al.
Published: (2020-07-01) -
Temoporfin-Conjugated Upconversion Nanoparticles for NIR-Induced Photodynamic Therapy: Studies with Pancreatic Adenocarcinoma Cells In Vitro and In Vivo
by: Oleksandr Shapoval, et al.
Published: (2023-11-01)